The historical rank and industry rank for Henan Lingrui Pharmaceutical Co's OCF Margin % or its related term are showing as below:
SHSE:600285'
s OCF Margin % Range Over the Past 10 Years
Min: 4.4 Med: 21.06 Max: 31.4
Current: 17.8
During the past 13 years, the highest OCF Margin % of Henan Lingrui Pharmaceutical Co was 31.40%. The lowest was 4.40%. And the median was 21.06%.
SHSE:600285's OCF Margin % is ranked better than 72.61% of 964
companies
in the Drug Manufacturers industry
Industry Median: 10.035
vs SHSE:600285: 17.80
Henan Lingrui Pharmaceutical Co OCF Margin % Related Terms
Henan Lingrui Pharmaceutical Co OCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Henan Lingrui Pharmaceutical Co OCF Margin % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Henan Lingrui Pharmaceutical Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Henan Lingrui Pharmaceutical Co OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Henan Lingrui Pharmaceutical Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Henan Lingrui Pharmaceutical Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Henan Lingrui Pharmaceutical Co (SHSE:600285) has a OCF Margin % of 23.84% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Henan Lingrui Pharmaceutical Co and its competitors. This is 13% above median its historical median of 21.06. Over the past decade, Henan Lingrui Pharmaceutical Co's OCF Margin % has ranged from 4.40 to 31.40. According to the industry distribution chart, Henan Lingrui Pharmaceutical Co ranks #264 out of 964 companies in the Drug Manufacturers industry, placing it in the top 27.4%.
Is Henan Lingrui Pharmaceutical Co's OCF Margin % too high?
Henan Lingrui Pharmaceutical Co's current OCF Margin % of 23.84% is 13% above median its 10-year median of 21.06. Over the past 10 years, this metric has ranged from a low of 4.40 to a high of 31.40. The Drug Manufacturers industry median OCF Margin % is 10.04. Henan Lingrui Pharmaceutical Co's value of 23.84% is 137.6% above this industry median. Based on the distribution chart, Henan Lingrui Pharmaceutical Co ranks #264 out of 964 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Henan Lingrui Pharmaceutical Co has a GF Score™ of 97/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Henan Lingrui Pharmaceutical Co's OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Henan Lingrui Pharmaceutical Co ranks #264 out of 964 companies for OCF Margin %. This puts Henan Lingrui Pharmaceutical Co in the upper half of its industry. The industry median OCF Margin % is 10.04. Henan Lingrui Pharmaceutical Co's value of 23.84% is 137.6% above this benchmark. Historically, Henan Lingrui Pharmaceutical Co's own OCF Margin % has ranged from 4.40 to 31.40 over the past decade. While the company's 10-year median is 21.06 vs. the industry median of 10.04, Henan Lingrui Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 10.04, based on 964 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Henan Lingrui Pharmaceutical Co's current OCF Margin % of 23.84% is 137.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Henan Lingrui Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 10.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Henan Lingrui Pharmaceutical Co's current OCF Margin % is 23.84%, which is 13% above median its own 10-year median of 21.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Henan Lingrui Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Henan Lingrui Pharmaceutical Co (SHSE:600285) is currently considered Fairly Valued. The stock's GF Value™ is ¥24.39, compared to a current price of ¥22.54 — trading 7.6% below its estimated fair value. The current OCF Margin % is 23.84%, which is 13% above median its 10-year median of 21.06 and 137.6% above the Drug Manufacturers industry median of 10.04. Henan Lingrui Pharmaceutical Co's overall GF Score™ is 97/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Henan Lingrui Pharmaceutical Co (SHSE:600285), the current OCF Margin % is 23.84% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Henan Lingrui Pharmaceutical Co (SHSE:600285) Overvalued in 2026?
Based on GuruFocus' analysis, Henan Lingrui Pharmaceutical Co stock appears to be undervalued.
The current stock price of ¥22.54 is trading 7.6% below its estimated GF Value™ of ¥24.39.
GuruFocus considers Henan Lingrui Pharmaceutical Co to be Fairly Valued.
Key valuation signals for SHSE:600285:
OCF Margin %: 23.84% (13% above median its 10-year median of 21.06)
GF Value™: ¥24.39 vs. price of ¥22.54 (7.6% below fair value)
Industry Position: 137.6% above the Drug Manufacturers median (#264 of 964)
No single metric tells the full story. See the SHSE:600285 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Henan Lingrui Pharmaceutical Co Business Description
Henan Lingrui Pharmaceutical Co Ltd is a Chinese company engaged in the development, production, and distribution of pharmaceuticals. The Company's products include tablets, capsules, injections and other medicines.
97GF Score
Get the complete analysis for SHSE:600285
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600285 has been successfully added to your 
